Which blood thinner is safer? new study seeks answers
NCT ID NCT02559856
Summary
This small pilot study aimed to see if a larger trial comparing two newer blood thinners (rivaroxaban and apixaban) for treating serious blood clots was possible. It enrolled 72 adults with newly diagnosed clots in their legs or lungs. The main goal was to test the process for a future study, while also gathering early information on which medication might cause fewer bleeding problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
-
Hôtel-Dieu de Sherbrooke
Sherbrooke, Quebec, J1G 2E8, Canada
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
University of Alberta
Edmonton, Alberta, T6G 2G3, Canada
Conditions
Explore the condition pages connected to this study.